Litcius/Paper detail

P21-activated kinase 2-mediated β-catenin signaling promotes cancer stemness and osimertinib resistance in EGFR-mutant non-small-cell lung cancer

Yanmei Yi, Pan Li, Yuanfeng Huang, Danyang Chen, Siwen Fan, Jun Wang, Minqiang Yang, Shanshan Zeng, Jin Deng, Xinwu Lv, Kai Luo, Zhiwei He, Hao Liu

2022Oncogene25 citationsDOI

Topics & Concepts

OsimertinibT790MCancer researchLung cancerEpidermal growth factor receptorBiologyKinaseTyrosine kinasenon-small cell lung cancer (NSCLC)CancerSignal transductionMedicineInternal medicineErlotinibGefitinibA549 cellCell biologyLung Cancer Treatments and MutationsCancer-related Molecular PathwaysLung Cancer Research Studies
P21-activated kinase 2-mediated β-catenin signaling promotes cancer stemness and osimertinib resistance in EGFR-mutant non-small-cell lung cancer | Litcius